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Available online 2 August 2013Abstract Primitive neural stem cells (NSCs) define an early stage of neural induction, thus provide a model to understand the
mechanism that controls initial neural commitment. In this study, we investigated primitive NSCs derived from mouse
embryonic stem cells (ESCs). By genome-wide transcriptional profiling, we revealed their unique signature and depicted the
molecular changes underlying critical cell fate transitions during early neural induction at a global level. Together with
qRT-PCR analysis, our data illustrated that primitive NSCs retained expression of key pluripotency genes Oct4 and Nanog, while
exhibiting repression of other pluripotency-related genes Zscan4, Foxp1 and Dusp9 and up-regulation of neural markers Sox1
and Hes1. The early differentiation feature in primitive NSCs was also supported by their intermediate characters on cell cycle
profiles. Moreover, re-plating primitive NSCs back to ESC culture condition could reverse them back to ESC stage, as shown by
reversible regulation of marker genes, cell cycle profile changes and enhanced embryoid body formation. In addition, our
microarray analysis also identified genes differentially expressed in primitive NSCs, and loss-of-function analysis demonstrated
that Hes1 and Ccdc141 play important function at this stage, opening up an opportunity to further understand the regulation of
early neural commitment.
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1092 W.-H. Tsang et al.Introduction direct ESCs to neural fate (Zhang et al., 2001; Kim et al., 2010;Blastocyst at early embryonic stage contains inner cell mass
(ICM) surrounded by an outer layer of trophectodermal cells.
The ICM cells are pluripotent, which can differentiate into
three lineages (ectoderm, mesoderm and endoderm) during
gastrulation and eventually give rise to all tissues in the
embryo (Rossant, 2008). The neuroectodermal tissue first
appears as a sheet of cells located along the dorsal midline
of the embryo, which is known as neural plate. Through a
complex process of folding and differentiation, neural plate
gives rise to various types of neurons and glial cells which
eventually constitute the entire nervous system. Hence the
emergence of neuroectoderm in neural plate marks the
initiation of neural induction.
ESCs derived from ICM retain the property of pluripotency
and can give rise to all types of somatic cells (Murry and Keller,
2008). In vitro differentiation of ESCs into functional neural
cells has been broadly demonstrated (Lang et al., 2004), which
constitutes a valuable cellular platform for depicting molecu-
lar basis underlying early neurogenesis, meanwhile it provides
a potential source of neural cells for treating injuries and
neurodegenerative conditions of the central nervous system
(CNS) through cell replacement therapy (Martino and Pluchino,
2006). Although the process of neural induction and develop-
ment of the nervous system have been relatively well
characterized using animal models, the exact molecular
events underlying the initiation of neurogenesis still remain
elusive. To date, understanding the precise cues that direct
pluripotent cells into neural lineage is a key challenge to
control neural commitment of ESCs and to generate defined
types of neural cells with high efficiencies.
Neural induction during embryogenesis is one of the earliest
events in specification of embryonic lineages (Weinstein and
Hemmati-Brivanlou, 1999). Consistently, formation of neuro-
ectodermal cells is commonly observed in spontaneous
differentiation of ESCs using conventional embryoid body
(EB) differentiation protocols (Watanabe et al., 2005).
However, EB-mediated differentiation often yields a cha-
otic mixture where different cell types with diverse spatial
and temporary identities co-exist. Hence, EB formation is
not suitable for analysis of the mechanism underlying
neural induction.
To reduce the complexity, conditions have been optimized
to induce neural differentiation fromESCs onmonolayer culture
(Zhang et al., 2001; Ying et al., 2003). Studies on morphogens
that promote neurogenesis at early embryonic stages have
concluded that neural induction from ESCs largely follows the
basic principles established in in vivo neurogenesis (Munoz-
Sanjuan and Brivanlou, 2002). Transforming growth factor-β
(TGFβ) and bone morphogenetic protein (BMP) signals, which
have been shown to inhibit neurogenesis in various animal
models (Hemmati-Brivanlou and Melton, 1994; Bachiller et al.,
2000), are involved in suppressing neural commitment of
ESCs by inducing mesodermal or endodermal differentiation
(D'Amour et al., 2005; Zhang et al., 2008). Fibroblast growth
factor (FGF), which is known to promote self-renewal of neural
stem cells (NSCs) in CNS (Launay et al., 1996; Streit et al.,
2000), can enhance neural differentiation of ESCs (Zhang et al.,
2001). In line with these notions, application of FGF ligands or
antagonists of TGFβ/BMP, in the form of either biological
molecules or synthesized chemical inhibitors, can robustlyMorizane et al., 2010). Further analysis on progressive
emergence of various neural cell types and their associated
marker gene expressions also showed that neural differentia-
tion process from ESCs highly resembles that in in vivo
neurogenesis (Elkabetz et al., 2008; Abranches et al., 2009).
However, the sequential emergence of intermediate neural
progenitor cells was not clearly defined in these studies, due to
heterogeneity of the culture in morphogen-directed monolayer
differentiation system.
Compared to the adherent monolayer culture, an alterna-
tive method using suspension culture has been shown to be
more effective in obtaining and maintaining the early neural
cells emerged during multi-staged differentiation process.
Using serum-free medium supplemented with epidermal
growth factor (EGF) and FGF, which selectively favor the
maintenance of NSCs isolated from CNS (Gage, 2000), ESCs
have been successfully induced into NSCs that could be
maintained in culture and retained the ability to further
differentiate into functional neurons and glial cells (Nakayama
et al., 2004). These EGF/FGF-dependent NSCs largely resem-
bled CNS-NSCs, which were termed definitive NSCs due to
their defined neural identity and robust capability of gener-
ating neurons and glia cells (Hitoshi et al., 2004; Smukler et
al., 2006; Rowland et al., 2011). The emergence of definitive
type of NSC also suggested that earlier stages of neural
induction were possibly bypassed in the EGF and FGF directed
neural induction. Interestingly, an earlier type of neural cells,
named primitive NSCs, has been established in the absence
of differentiation-inducing cues using suspension culture
(Tropepe et al., 2001; Smukler et al., 2006). These primitive
NSCs resembled early stage neural cells isolated from E5.5–
E7.5 embryonic neuroectoderm (Hitoshi et al., 2004), a stage
before CNS formation and emergence of definitive NSCs. These
primitive NSCs grew in a leukemia inhibitory factor (LIF)-
dependent manner, and expressed pluripotency genes Oct4
and Nanog as well as early neural markers Sox1 and Hes1
(Hitoshi et al., 2004), but not conventional markers found
in more committed CNS-NSCs, such as Nestin and Pax6
(Rowland et al., 2011). Further induction in culture medium
supplemented with FGF and EGF could direct these
primitive NSCs to definitive type of NSCs (Tropepe et al.,
2001; Hitoshi et al., 2004; Rowland et al., 2011), suggesting
that primitive NSCs obtained using this method define an
early stage of neural induction. Further study on this cell
type may facilitate unveiling of the molecular regulations
underlying initial neural commitment, which still remains
obscure due to the complex and fast-changing nature of
early neural induction process.
In this study, we took one step forward to further
investigate the LIF-dependent primitive NSCs. For the first
time we analyzed global gene expression profiles in mouse
ESC-derived primitive NSCs and identified groups of genes
which were specifically up- or down-regulated in these cells
using Affymetrix DNA microarray. Our data illustrated that
primitive NSCs retained the expression of many pluripotency
genes while exhibiting gene expression changes associated
with ESC differentiation. Cell cycle analysis further support-
ed that primitive NSCs exhibited intermediate features
between mouse ESCs and CNS-derived definitive NSCs. By
re-plating primitive NSCs back to ESC culture conditions,
these cells could be reverted back to ESC stage from early
1093neural committed stage, which was further supported by the
reversible regulation of early neural genes and cell cycle
profiles changes. Importantly, our loss-of-function analysis
identified Hes1 and Ccdc141 as potential regulators in early
neural induction. Thus our study clarified features of
primitive NSCs as early neural cells and shed light on
the mechanism underlying the early neural commitment
from ESCs.Materials and methods
Mouse ESC culture
R1 mouse ESCs were maintained as previously described
(Feng et al., 2009). Briefly, cells were cultured on mitomycin
C-inactivated mouse embryonic fibroblast feeder in DMEM
containing 15% FBS, 1 mM sodium pyruvate, 1% MEM non-
essential amino acids, 2 mM L-glutamine, 0.1 mM 2-
mercaptoethanol and 1000 U/ml LIF (Life Technologies).
The ESC colonies were completely dissociated using
0.25% Trypsin–EDTA and re-plated onto new feeders
every two days.Induction of primitive and definitive NSCs
To generate primitive NSCs, mouse ESCs were dissociated
using 0.25% Trypsin–EDTA and plated at a density of 20 cells/μl
into uncoated Petri dish, with serum-free medium (Tropepe
et al., 2001; Smukler et al., 2006) containing DMEM/F-12
medium supplementedwith N2 supplement (Life Technologies)
and 1000 U/ml LIF. Primary spheres appeared after 5–7 days,
and were dissociated using Accutase (Life Technologies) and
re-plated in medium containing 1000 U/ml LIF, 10 ng/ml FGF
(PeproTech) and 2 μg/ml Heparin (Sigma) (Tropepe et al.,
2001; Smukler et al., 2006). Definitive NSCs were induced
by passaging primitive NSCs into DMEM/F-12 medium
supplemented with N2 and B27 supplement (Life Technol-
ogies), 20 ng/ml EGF (PeproTech), 20 ng/ml FGF and
2 μg/ml Heparin (Smukler et al., 2006). Spheres were
fully dissociated and re-plated every 5–7 days.
To re-plate p-NSC (data shown in Fig. 4), neurospheres were
dissociated using Accutase (Life Technologies) and cultured in
mESC condition as described above. For experiments shown in
Supplementary Fig. 4, intact p-NSC neurospheres were plated
on feeder using ESC culture medium. After attachment for one
day, cells were stained against SSEA-1. Individual SSEA-1(+) and
SSEA-1(−) clones were then manually transferred into single
wells in 24-well plates and expanded for three passages before
immunofluorescence analysis as described below.EB-mediated in vitro differentiation
Mouse ESC, p-NSC or re-plated p-NSC was dissociated and
cultured in bacterial culture dish for four days in ESC
medium without β-mercaptoethanol and LIF to form embry-
oid bodies (EB). EB were then plated into gelatin-coated
24-well dish, and cultured for an additional 4–7 days in the
presence of 1 μM retinoic acid (Sigma). Samples were then
fixed for immunofluorescence analysis as described below.In vitro differentiation of definitive NSCs
In vitro differentiation of definitive NSCs was induced as
previously described (Tropepe et al., 2001; Smukler et al.,
2006). Briefly, neurospheres of definitive NSCs or CNS-NSCs
were dissociated using Accutase (Life Technologies) and
seeded in culture plates pre-coated with Matrigel (BD
Biosciences) at a density of 2500 cells/cm2, in DMEM/F-12
medium supplemented with 1% FBS (Life Technologies).
Cultures were fixed for immunofluorescence after seven
days of induction.
Isolation and culture of CNS-NSCs
From E11.5 mouse embryos, the frontal lobes of each embryo
brain were manually dissected and CNS-NSCs were collected
from the tissues by trituration and were cultured in DMEM/
F-12 medium supplemented with N2, 20 ng/ml EGF, 20 ng/ml
FGF and 2 μg/ml Heparin (Smukler et al., 2006). Neurospheres
were then fully dissociated using Accutase and re-plated every
5–7 days.
Immunofluorescence
Cells or spheres were fixed using 4% paraformaldehyde
(Sigma) in PBS. Cell membrane was permeabilized using 1%
Triton X-100/PBS and non-specific binding was blocked with
8% FBS in 0.1% Tween-20/PBS. The samples were then
incubated with primary antibody diluted in blocking solution
at 4 °C overnight, followed by incubation with Alexafluor
488- or Alexafluor 546-conjugated secondary antibodies at
room temperature for 2–4 h. Nuclei were counterstained by
Hoechst dye 1:5000 (Life Technologies). Primary antibodies
used were βIII-Tubulin (1:50, Santa Cruz), GFAP (1:100,
Chemicon), SSEA-1 (1:500, Santa Cruz), Gata-4 (1:200, Santa
Cruz), α-Smooth Muscle Actin (1:200, Abcam), and Nestin
(1:200, Abcam).
Knockdown of genes with shRNA constructs
Two shRNA for each gene were designed using WI siRNA
selection program http://jura.wi.mit.edu/bioc/siRNAext/.
Synthesized oligonucleotides were cloned into pSUPER.puro
(BglII and HindIII sites; Oligoengine). Transfection of ESC for
the knockdown experiment was performed as described
previously according to the manufacturer's instructions.
Briefly, 0.8 μg of shRNA construct (pSuper, Oligoengine)
and 2 μl of Lipofectamine 2000 (Life Technologies) were
used for transfection into ESC in 24-well dishes. 0.8 μg/ml of
puromycin was added to the culture medium 24 h after
transfection. Cells were harvested for RNA extraction or
p-NSC derivation after 4 days.
Quantitative real-time PCR
Total RNA was extracted from cell samples using TRIzol
reagent (Life Technologies) and reverse-transcribed into cDNA
using High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). Quantitative real-time PCR was performed with
Power SYBR Green PCR Master Mix (Applied Biosystems) in an
1094 W.-H. Tsang et al.ABI7900HT Real Time PCR system. Measured transcript was
normalized to GAPDH and samples were run in triplicate.
Flow cytometry analysis
ESCs and NSCs were dissociated into single cells and fixed with
pre-chilled 80% ethanol. These cells were stained with 40 μg/
ml propidium iodide (Sigma) supplemented with 40 μg/ml
RNase solution (Life Technologies) at 37 °C for 30 min. Cell
cycle analyses were carried out with BD LSRFortessa Cell
Analyzer, and data was analyzed using BD FACSDiva software.
Affymetrix microarray gene chip analysis
Total RNA from each sample were converted to cDNA and
subsequently to cRNA using WT Expression Kit (Ambion). cRNA
sampleswere then fragmented, biotinylated and hybridized to
GeneChip Mouse Gene 1.0 ST Array (Affymetrix). Washing and
scanning steps were performed with GeneChip Systems for
array cartridges (Affymetrix) and obtained datawere analyzed
using Partek Genomics Suite (Partek) and Ingenuity Pathway
Analysis (IPA). Fold change was shown in log2 scale and signals
with fold change ≥2 or ≤−2 were considered as differentially
expressed genes. The microarray data were deposited into
NCBI, and the accession number is GSE44608.
Results
Primitive NSCs represent an early stage of neural
commitment
Induction of primitive NSCs (p-NSC) from mouse ESCs was
initiated by culturing single cells in suspension with serum-
free medium containing LIF (Fig. 1A), which was described
previously as the “default mechanism” (Tropepe et al., 2001;
Smukler et al., 2006; Rowland et al., 2011). We observed that
smooth neurospheres (p-NSC_L) emerged with an efficiency
ranging from 0.05% to 0.1%, within five to seven days (Fig. 1B,
left panel). When these primary neurospheres were dissociated
into single cells, they could re-colonize into new spheres with
additional supplement of FGF (p-NSC_LF) (Fig. 1B, middle
panel), but not with LIF alone. These p-NSCs could be
maintained in culture for 3–5 passages. To examine whether
these p-NSCs could further differentiate into definitive NSCs
(d-NSCs), we cultured the p-NSCs in medium containing FGF
and EGF. Indeed, new spheres bearing a characteristic rough
surface could be formed (Fig. 1B, right panel). We then
sub-cultured these spheres in medium containing 1% serum,
which is known to induce lineage-specific differentiation
of CNS-NSCs and generate more committed neuronal cells
(Karimi-Abdolrezaee et al., 2006). After seven days of induc-
tion, immunofluorescence detected a positive staining of
βIII-Tubulin (Tubb3) and glial fibrillary acidic protein (GFAP),
indicating the formation of mature neurons and astrocytes
(Fig. 1C). This result is consistent with the neurogenic potential
described in CNS-NSCs, suggesting that p-NSCs were early stage
neural cells that could give rise to more differentiated d-NSC
before commitment to develop into neurons and glial cells.
Mouse ESCs undergo rapid cell division with a short G1
phase, which is a characteristic and determining factor inmaintaining their pluripotency state and self-renewal
(Coronado et al., 2013). To understand the cellular changes
occurred during ESC differentiation into p-NSC and d-NSC,
we examined cell cycle profiles in these cells. Indeed, a
large population of ESCs was observed in S phase and G2/M
phase, indicating a high proliferation capacity of these cells
(Fig. 1D, upper left panel). Interestingly, p-NSCs exhibited a
cell cycle structure similar to that of ESCs, except a slightly
reduced population in G2/M phase (Fig. 1D, upper right
panel). This indicated a minor reduction of proliferation rate
in these cells, suggesting that p-NSCs might be at an early
stage of differentiation. In contrast, d-NSCs highly resem-
bled CNS-NSCs, showing a relatively low population in both S
phase and G2/M phase (Fig. 1D, lower left and right panels),
which is a typical feature of somatic cells (Stead et al.,
2002). This indicated that d-NSCs have committed to
differentiation and acquired somatic cell fate.
We further carried out qRT-PCR analysis on pluripotency
genes, early neural markers and d-NSC markers. Key plu-
ripotency genes Oct4, Nanog and Sox2 (Ng and Surani, 2011)
were found to be highly expressed in ESCs, p-NSCs derived
directly from ESCs in LIF (p-NSC_L) as well as p-NSCs that
were sub-cultured in the presence of LIF and FGF (p-NSC_LF)
(Fig. 1E). This result indicated that p-NSC still retained some
features of ESC. In contrast, d-NSC, CNS-NSC and EB, which
were more differentiated cell types, exhibited significant
down-regulation of Oct4 and Nanog expression (Fig. 1E).
Pluripotency gene Sox2 is reported to be a universal marker of
NSC and neural progenitors (Ellis et al., 2004). Other than ESC,
it was also highly expressed in p-NSC, d-NSC and CNS-NSC
(Fig. 1E), indicating neural identity in these cells. Early neural
markers Sox1 and Hes1 were up-regulated in p-NSC (Fig. 1F)
while d-NSC markers Nestin, Pax6 and Hes5 could only be
detected in CNS-NSC and d-NSC (Fig. 1G).
Collectively, our results indicated that p-NSCs obtained
belong to neural cells at an early stage while retaining
certain ESC characters. These cells could further differen-
tiate into d-NSC, subsequently to mature neurons and
astrocytes.Global gene expression analysis on primitive NSCs
revealed the molecular mechanisms underlying
neural differentiation
To understand the molecular basis of neural induction, we
performed microarray assay to further depict the molecular
changes in p-NSCs during multi-staged neural commitment.
Side by side comparisons were carried out in p-NSC_L,
p-NSC_LF, d-NSC, mouse ESC and CNS-NSC. Dendrogram of
unsupervised one-way hierarchical clustering analysis was
calculated by Pearson's correlation based on differentially
expressed genes among all samples (fold change ≥2 or ≤−2,
p b 0.05). The clustering result showed that p-NSC_L and
p-NSC_LF shared a high similarity in their expression profiles
(Fig. 2A), suggesting that p-NSCs could sustain a relatively
stable status since the initial derivation from ESCs. The gene
expression profile in d-NSC resembled that in CNS-NSC
(Fig. 2A), indicating that the d-NSCs obtained have committed
to conventional definitive type NSC fate. Interestingly, both
p-NSC_L and p-NSC_LF samples showed subtle difference
from mouse ESC, yet significantly differed from d-NSC and
ED
C
B
200 µmp-
NS
C_
L
p-
NS
C_
LF
d-
NS
C
A
Neurons
Astrocytes
Oligodendrocytes
Lif
Lif/FGF
FGF/EGF
Mouse ESC Primitive NSC Definitive NSC
Serum
Tubb3/Hoechst GFAP/Hoechst
50 µm
F
G
Co
un
t
DNA
2N 4N
Mouse ESCs Primitive NSCs
CNS-NSCsDefinitive NSCs
S
G1 G2/M
S
G1 G2/M
S
G1 G2/M
S
G1 G2/M
2N 4N
mESC
EB
p-NSC_L
p-NSC_LF
d-NSC
CNS-NSCR
el
at
iv
e 
ex
pr
es
sio
n
  50
  100
  150
  200
  250
  5
  0
  10
  15
0
1
2
3
4
5
6
Nestin         Hes5    Pax6
mESC
EB
p-NSC_L
p-NSC_LF
d-NSC
CNS-NSC
R
el
at
iv
e 
ex
pr
es
sio
n
R
el
at
iv
e 
ex
pr
es
sio
n
0
0.5
1
1.5
2
2.5
Oct4 Nanog Sox2
10
8
6
4
2
0
Sox1
5
4
3
2
1
0
Hes1
mESC
EB
p-NSC_L
p-NSC_LF
G1: 25.0%
S: 49.7%
G2/M: 25.1%
G1: 73.7%
S: 15.2%
G2/M: 11.1%
G1: 70.3%
S: 15.2%
G2/M: 11.1%
G1: 34.5%
S: 49.3%
G2/M: 16.1%
Figure 1 Characterization of primitive NSCs. (A) Schematic representation of step-wise neural induction of mouse ESCs. ESC:
embryonic stem cells; NSC: neural stem cells; LIF: leukemia inhibitory factor; FGF, fibroblast growth factor; EGF, epidermal growth
factor. (B) Representative images of p-NSC neurospheres derived in LIF (p-NSC_L), p-NSC neurospheres re-colonized in LIF and FGF
(p-NSC_LF), and d-NSC neurospheres derived and cultured in EGF and FGF. (C) Immunofluorescence detection of neurons (Tubb3
positive) and astrocytes (GFAP positive) that were differentiated from d-NSCs. Nuclei were counterstained with Hoechst. (D) Flow
cytometric analysis on cell cycle profiles of mouse ESCs, p-NSCs, d-NSCs and CNS-NSCs. (E) Expression of Oct4, Nanog and Sox2
analyzed by qRT-PCR in mouse ESCs, EB, and p-NSCs, d-NSCs and CNS-NSCs. Data were shown as mean ± SEM (n = 3). (F) Expression of
Sox1 and Hes1 analyzed by qRT-PCR. Data were shown as mean ± SEM (n = 3). (G) Expression of Nestin, Hes5 and Pax6 analyzed by
qRT-PCR. Data were shown as mean ± SEM (n = 3).
1095CNS-NSC. This was in line with the cell cycle analysis as well
as qRT-PCR result (Fig. 1D–G), suggesting that p-NSCs
represented an early stage neural cell type which was closely
related to ESCs rather thanCNS-NSCs and d-NSCs. Consistently,
p-NSCs and mouse ESCs also revealed a strong correlation in
their global gene expression profiles, with correlation coeffi-
cients (R2) ranking from 0.97 to 0.98; whereas the correlation
of p-NSCs to CNS-NSCs varied between 0.91 and 0.92 (Fig. 2B).
Next, we grouped the two p-NSC samples and compared
their gene expression profiles to that in ESC and d-NSC
separately. By comparing p-NSC and ESC, we identified 278
down-regulated genes and 207 up-regulated genes in p-NSC;
whereas between d-NSC and p-NSC, 1440 genes were found
to be down-regulated and 1840 genes were up-regulated in
d-NSC. To further depict these data and obtain functionalannotation, we carried out Gene Ontology (GO) analysis
using DAVID (http://david.abcc.ncifcrf.gov/). Interestingly,
in both comparisons, i.e. between p-NSC and ESC and
between d-NSC and p-NSC, differentially expressed genes
(both up- and down-regulated) were found to be enriched in
biological processes related to transcriptional regulation
(Fig. 2C and D). It suggested that this neural differentiation
process was mainly driven by alteration of transcription,
which is consistent with the notion that transcription factors
often play key roles in cell fate determination and organo-
genesis during embryonic development. In addition, we also
noticed that a large group of differentially expressed genes
were associated with plasma membrane components in the
cell, and enriched in relevant GO terms (Fig. 2E, red
arrows). These genes are worth further investigation, as
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transcription profiles in p-NSC_LF vs. mouse ESC, and in p-NSC_LF vs. CNS-NSC. (C) Gene Ontology (GO) analysis on genes
differentially expressed between p-NSC (average of p-NSC_L and p-NSC_LF) and mouse ESC using DAVID. Enriched GO terms in
Biological Process ontology were selectively shown. (D) GO analysis on genes differentially expressed between d-NSC and p-NSC using
DAVID. Enriched GO terms in Biological Process ontology were selectively shown. (E) Top five enriched GO terms in Cellular
Component ontology were shown for genes differentially expressed among mouse ESC, p-NSC and d-NSC. Red arrows indicate the GO
terms related to plasma membrane. (F) Venn diagram showing numbers of genes down- or up-regulated in p-NSC vs. mESC (left
panel), or in d-NSC vs. p-NSC (right panel). Neural-related genes were indicated in the green circles. (G) Forest plot showing the
expression changes of differentiation-related genes in p-NSCs vs. mESC (left panel) and p-NSC vs. d-NSC (right panel). The
differentiation related genes were selected from the Gene Oncology database under the grouping of “cell differentiation”. Numbers
of up-regulated genes were indicated as yellow bars, and numbers of down-regulated genes were indicated in blue bars.
1096 W.-H. Tsang et al.they have potential to be developed as cell surface markers
of early neural cells.
Further analysis on the microarray data also revealed
global gene expression changes occurred during the differ-
entiation from ESC to p-NSC then to d-NSC. As reflected by
the number of differentially expressed genes, more drastic
global changes were observed during the transition from
p-NSC to d-NSC (1440 genes down-regulated and 1840 genes
up-regulated), compared to that from mouse ESCs to p-NSC(278 genes down-regulated and 207 genes up-regulated).
Consistently, among the 443 genes which were neural
related, 193 genes were activated during p-NSC to d-NSC
transition (Fig. 2F, right panel), whereas only 14 genes
were up-regulated (Fig. 2F, left panel) from ESC state to
p-NSCs. In addition, activation of differentiation-related
genes was also mainly observed during the transition from
p-NSC to d-NSC (Fig. 2G). Taken together, these data
indicated that p-NSCs represent an early stage of neural
1097commitment, whereas the d-NSCs represent substantial
acquisition of neural cell identities which involved drastic
changes in global gene expression.
The high similarity between p-NSC and ESC led us to
examine the similarity between p-NSC and another type of
ES-like stem cells, epiblast stem cells (EpiSC) (Tesar et al.,
2007). Mouse EpiSC are derived from post-implantation
mouse embryos and are thought to represent a status of
pluripotency primed to differentiation. Microarray data on
EpiSC were obtained from public database (GEO) (Tesar
et al., 2007). Using mouse ESC as a reference cell type, the
number of up- or down-regulated genes in EpiSC and p-NSC
was compared using a Venn diagram. The result indicated
that there is very little overlap between the EpiSC and p-NSC
enriched genes (Supplementary Fig. 1A). mRNA level of
genes typically enriched in mESC or EpiSC was also analyzed
in p-NSC. The result showed that p-NSC expressed reduced
level of mESC-enriched genes Zfp42, Esrrb and Dax1, while
the EpiSC-enriched genes Cer1, Fgf5 and Foxa2 were
completely absent (Supplementary Fig. 1B). Conversely,
genes that were up-regulated in p-NSC were found to be
either repressed (such as Ccdc141 and Ablim1) or further
up-regulated in EpiSC (such as Tcfp2a) (Supplementary Fig.
1B). These results suggested that p-NSC represents a
distinct cell type from EpiSC.Primitive NSCs exhibit differentiation-associated
gene expression changes
Next, we focused on the analysis of genes differentially
expressed in p-NSCs and ESCs (Fig. 3A). Interestingly, the
278 genes that were down-regulated upon the formation of
p-NSCs included several genes that were recently discov-
ered in maintaining pluripotency or associated properties
in ESCs (Fig. 3B). Zscan4 is reported to regulate telomere
elongation and genomic stability in 2-cell stage embryos
and ESCs (Zalzman et al., 2010). In our microarray data, an
ESC-specific paralogue Zscan4c was drastically down-
regulated by over 19 fold in p-NSC, compared to that in
ESC. Usp44 encodes a deubiquitinase enriched in ESC. It
negatively regulates histone ubiquitylation and prevents
rapid differentiation of ESCs (Fuchs et al., 2012). Dusp9
encodes a dual-specificity phosphatase that specifically
phosphorylates ERK and inhibits mouse ESC differentiation
(Li et al., 2012). In our microarray data, Usp44 and Dusp9
transcription was down-regulated in p-NSC by 2.15 to 2.52
fold, respectively. In addition, Foxp1, Dppa3 and Dnmt3a,
which are known to associate with undifferentiated ESCs
(Bowles et al., 2003; Chen et al., 2003; Gabut et al., 2011),
were also found to be down-regulated during the transition
from ESCs to p-NSCs. The down-regulation of these differen-
tiation inhibitors in our data suggested that p-NSCs indeed
underwent lineage commitment.
On the other hand, very few established neural markers
were found within the 207 genes that were up-regulated in
p-NSC. For instance, activation of traditional CNS-NSC marker
genes Nestin, Pax6 and Hes5 was not observed in p-NSC.
Instead, several genes that have not been shown to involve in
neural lineage specification but implicated in neural-related
functions in either late embryonic or adult stagewere found to
be included (Fig. 3B). Among which, Hmga2 was shown topromote self-renewal of NSCs derived from young mice
(Nishino et al., 2008), while Satb2 was shown to regulate
callosal projection neuron identity in the developing brain
(Alcamo et al., 2008). Ccdc141 encodes a coiled-coil domain
protein. Its homologue in human is known to interact with
Disrupted-in-Schizophrenia 1 (DISC1) and play a role in
DISC1-related mental diseases including schizophrenia and
autism (Fukuda et al., 2010). The significant up-regulation
of these genes in p-NSCs revealed their potential roles
during early neural induction.
Concordant with microarray data, qRT-PCR analysis further
confirmed that ESC genes Zscan4, Usp44, Foxp1, Dusp9, Dppa3
and Dnmt3a were down-regulated in p-NSCs (Fig. 3C, left
panel). PCR primers were also designed to detect an
ESC-specific isoform of Foxp1 (Foxp1-ES) (Gabut et al., 2011).
The overall transcription of Foxp1was reduced to 57% in p-NSC
while the Foxp1-ES variant exhibited a further reduction to 22%
(Fig. 3C, left panel). On the other hand, the up-regulation of
neural genes Ccdc141, Satb2,Hmga2, Bcl6 (Tiberi et al., 2012),
Meis2 (Oulad-Abdelghani et al., 1997), Ablim1 (McIntyre et al.,
2010) and Tcfap2a (Brewer et al., 2004) from ESC to p-NSC was
also confirmed by qRT-PCR analysis (Fig. 3C, right panel).
To further validate these findings, we carried out loss-
of-function analysis on selected p-NSC-enriched genes. Mouse
ESCs were transfected with individual shRNA targeting to the
candidate transcripts, followed by qRT-PCR analysis and p-NSC
sphere formation assay. We found that, without showing
obvious alteration on ESC growth, depletion of Hes1 and
Ccdc141 caused severe reduction in p-NSC sphere formation
(Fig. 3D, E). Hes1 was known to be an early neural marker
during embryogenesis (Hitoshi et al., 2004), our result of Hes1
knockdown is consistent with this knowledge, confirming its
role as an important regulator of early neural induction.
Intriguingly, Ccdc141 is first time found to be associated with
neural induction (Fig. 3A–C), and our result from the
knockdown experiment (Fig. 3D, E; Supplementary Fig. 2)
strongly suggested that Ccdc141 plays an important role at this
stage. Further investigation into the underlying mechanism of
Ccdc141's function is currently in progress.
We also analyzed the global gene expression data with
Ingenuity Pathway Analysis (IPA) software. In line with the
acquisition of FGF dependence upon transition of mouse
ESCs to p-NSCs, several genes related to FGF/ERK signaling,
including FGF10, FGF17, FGF18 and Etv4, were found to be
altered (Supplementary Fig. 3).Primitive NSCs represent a reversible stage of
neural differentiation
Since p-NSCs showed intermediate features between undif-
ferentiated and differentiated cells, we would like to know
if p-NSCs could be reverted back to ESC state simply by
switching back to mouse ESC medium and providing feeder
for attachment. Indeed, we found that p-NSCs re-plated in
ESC culture condition could form mouse ESC-like colonies
within two days (Fig. 4A), which was comparable to mouse
ESCs. Although the re-colonization efficiency of freshly
re-plated p-NSCs was 20–30% lower than that of mouse
ESCs (Fig. 4B), the growth rate of both re-plated p-NSCs and
control mouse ESCs was similar (Fig. 4C), and they showed
no obvious morphological differences after four passages. In
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Figure 3 Differentiation-associated gene expression changes observed in p-NSCs. (A) Heat map of 278 genes down-regulated and
207 genes up-regulated in p-NSCs, compared with ESCs. Up- or down-regulated genes were selected based on gene expression
changes (fold change ≥2 or ≤−2, p b 0.05). (B) Down-regulated genes that have been shown to be involved in the maintenance of
pluripotency in ESCs, and up-regulated genes that have been shown to be related to neural functions in p-NSC. (C) qRT-PCR analysis of
selected up- and down-regulated genes from (B). (D) Formation of p-NSC neurospheres from mock, Ccdc141 shRNA, Hes1 shRNA, Satb2
shRNA and Meis2 shRNA treated mESCs. (E) Images of p-NSC neurospheres formed from untransfected control, mock, as well as
Ccdc141 and Hes1 knockdown mESCs.
1098 W.-H. Tsang et al.contrast, re-plated d-NSCs and CNS-NSCs failed to re-colonize
and no colony could be observed within two days (Fig. 4B).
We further examined cell cycle profiles in p-NSCs before
and after re-plating. Compared to freshly derived p-NSCs,
re-plated p-NSCs showed a higher proportion of cells in G2/M
phase (Fig. 4D), which was similar to the profile in mouse
ESC (Fig. 1D). More importantly, a reversible regulation of
early neural genes Sox1 and Hes1 was revealed by qRT-PCR
analysis (Fig. 4E). While the expression of Sox1 and Hes1 was
initially increased upon p-NSC formation from ESCs, these
up-regulations could be reversed by re-plating these p-NSCs
back to ESC condition and stably maintained at a low level
during successive passages under the same condition.
Since p-NSC express Oct4, Sox2 and Nanog at a comparable
level to mouse ESC, we sought to analyze another ESC-specific
marker, SSEA-1 to determine its reversibility back tomouse ESC
status. SSEA-1 is characterized by its heterogeneous expression
in undifferentiated ESCs and rapid loss upon ESC differentiation
(Cui et al., 2004). As expected, the number of SSEA-1(+)
colonies was significantly decreased during the transition from
ESC to p-NSC (Fig. 4F, G). Interestingly, this reduction was
reversed in re-plated p-NSCs (Fig. 4G). To examine if the loss of
SSEA-1 expression in SSEA-1(−) p-NSC could be reversed, we
further re-plated individual p-NSC spheres. By staining live cells
against SSEA-1, we found that SSEA-1(−) spheres couldre-colonize efficiently and give rise to both SSEA-1(+) and
SSEA-1(−) colonies in mESC culture condition (Supplementary
Fig. 4). This indicated that SSEA-1(−) p-NSCs were directed but
not fully committed to neural differentiation, supporting that
p-NSCs represent a reversible stage of neural differentiation.
To test whether re-plated p-NSC also re-gained the
differentiation capacity of ESCs, we performed the EB
formation assay. Compared to p-NSCs, which failed to form
EB efficiently after dissociation into single cells, the re-
plated p-NSCs formed EB robustly and could give rise to cell
types of all three germ layers (Fig. 4H).
Collectively, these data suggested that although p-NSCs
were partially committed to the neural lineage, their early
stage neural identity could be reverted back to the ESC stage.Discussion
Definitive NSCs, including CNS-derived NSC and their in vitro
counterparts derived from ESC, can give rise to various
neuronal cell types. Thus it has raised the possibility of
treating injuries and neurodegenerative conditions of CNS
through cell replacement therapy (Martino and Pluchino,
2006). However, although these NSCs can be maintained in
culture, they exist in a form of heterogeneous population
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Figure 4 Reversion of p-NSCs back to ESC stage. (A) Images showing the colonies formed by mouse ESCs and re-plated p-NSCs in ESC
condition after three passages. (B) Recolonization efficiency of mouse ESC, p-NSC, d-NSC and CNS-NSC. Shown are number of colonies
formed from every 100 starting cells. Data were shown as mean ± SEM (n = 3). (C) Growth of mouse ESC and re-plated p-NSC. 2 × 104
cells were seeded at day one and cell numbers were recorded every two days. Growth of re-plated p-NSC was monitored from passage
3 to 5 after being re-plated in ESC culture condition. Data were shown as mean ± SEM (n = 3). (D) Cell cycle analysis of p-NSC and
re-plated p-NSC after three passages. (E) Expression of Sox1 and Hes1 was analyzed in ESC, p-NSCs and p-NSCs re-plated in ESC
condition for four passages. Data were shown as mean ± SEM (n = 3). (F) Immunofluorescence staining of p-NSC spheres with antibody
against SSEA-1. SSEA-1(−) spheres were indicated with arrows. (G) Quantification of SSEA-1(+) and SSEA-1(−) colonies in mouse ESC,
p-NSC and p-NSC re-plated in ESC condition after three passages. (H) Differentiation of re-plated p-NSC via EB formation.
Representative images of differentiated cells expressing Nestin (neural ectoderm), α-Smooth Muscle Actin (mesoderm) or Gata-4
(endoderm). Nuclei were counterstained with Hoechst. Scale bars = 50 μm.
1099comprising of multipotent NSCs and committed neural precur-
sor cells (Temple, 1989; Tropepe et al., 1999). Moreover,
properties of CNS-NSCs depend on their origins in the brain and
their stages of development (Temple, 2001); characteristics of
ESC-derived NSCs vary according to the induction procedures.
As there is no available method to further purify these diverse
subtypes efficiently, application of NSCs in clinical therapies is
greatly hindered. p-NSCs, a kind of earlier stage NSCs, have
been obtained from neuroectoderm prior to CNS formation
(Hitoshi et al., 2004), and their equivalent cell type can be
derived from mouse ESCs in suspension culture condition
(Tropepe et al., 2001; Hitoshi et al., 2004; Smukler et al.,2006; Rowland et al., 2011). Compared to CNS-NSCs, p-NSCs
represent early stage neural cells. Thus they have opened up a
new area in NSC study, which may facilitate unraveling of the
mechanism that leads to heterogeneity and diversity among
NSCs.
In this study, we investigated the cellular and molecular
features of p-NSCs, derived from mouse ESCs via “default
mechanism”, a method that was reported to enrich p-NSC
(Tropepe et al., 2001; Smukler et al., 2006; Rowland et al.,
2011). We showed that p-NSCs have a decreased G2/M
population compared to ESCs and similar to cells at early
differentiation stages (Coronado et al., 2013); whereas
1100 W.-H. Tsang et al.d-NSCs highly resembled CNS-NSCs, showing typical cell
cycle features of somatic cells (Stead et al., 2002). Further-
more, this is the first report to reveal the global expression
profile of p-NSCs. Genes differentially expressed among ESC,
p-NSC and d-NSC have been identified (Fig. 2A), providing new
clue to unravel novel regulators in early neural induction. The
global profiling analysis also provided an overview of gene
expression changes during early neural induction, illustrating
drastic changes occurred during p-NSC to d-NSC transition,
rather than from ESCs to p-NSCs (Fig. 2F, G). Together with
the cell cycle analysis, it indicated that p-NSC is an
intermediate cell type that is more closely related to ESC,
compared to d-NSC and CNS-NSC.
Our data also supported that p-NSCs were indeed commit-
ted to differentiation (Fig. 3). 278 ESC-enriched genes were
found to decrease significantly in p-NSC (Fig. 3A). These
included Zscan4, Usp44, Dusp9, Foxp1 etc., which have been
shown to be down-regulated upon ESC differentiation previ-
ously (Zalzman et al., 2010; Gabut et al., 2011; Fuchs et al.,
2012; Li et al., 2012). On the other hand, 207 genes, including
someneural-related genesCcdc141,Hgma2, Satb2 etc. (Alcamo
et al., 2008; Nishino et al., 2008; Fukuda et al., 2010), were
found to be up-regulated (Fig. 3A–C). Importantly, our result
showed that silencing of Ccdc141 and Hes1 severely impeded
the p-NSC sphere formation (Fig. 3D, E), suggesting that their
up-regulation is critical to p-NSC derivation. This data prompts
to the conclusion that Ccdc141 is a potential novel regulator of
early neurogenesis.
Intriguingly, our study showed that p-NSCs could be
converted back to ESC state after re-plating in ESC culture
conditions (Fig. 4), which was supported by the decreased
expression of Sox1 and Hes1, increased SSEA-1 as well as the
reversible cell cycle profile. This suggested that p-NSCs
represent a reversible stage of neural commitment.
Our results are consistent with recent reports on mouse
ESC-derived p-NSCs. Tropepe et al. and Rowland et al. have
confirmed the broad developmental potential in p-NSCs
through in vivo microinjection into mouse embryos and in
vitro differentiation into broad range of cell types (Tropepe
et al., 2001; Rowland et al., 2011). This suggested that p-NSCs
have not fully committed to neural differentiation and
retained some features of pluripotent cells. In addition,
although some early publications reported the expression of
Nestin in p-NSCs (Tropepe et al., 2001; Hitoshi et al., 2004),
recent studies revealed that CNS-NSC markers Nestin and
Pax6 were more likely maintained at a low level in p-NSCs
(Rowland et al., 2011; Salewski et al., 2013). In line with
these works, our study confirmed the expression of Oct4
and Nanog and suppression of Nestin and Pax6 in p-NSCs
(Fig. 1E, G).
Other than derivation of p-NSC from mouse ESCs, the
induction of LIF-dependent primitive neural precursors from
human ESCs has also been investigated on monolayer culture
(Li et al., 2011). However, the cells obtained showed rapid
down-regulation of Oct4 and Nanog with abundant expres-
sion of definitive NSC markers Nestin and Pax6 (Li et al.,
2011), which were inconsistent with the features exhibited
by the p-NSCs derived from mouse ESCs (Rowland et al.,
2011). It is not clear whether the discrepancy was caused by
profound difference between mouse and human ESCs, or due
to the difference between culturing methods, i.e. attach-
ment vs. suspension.On the other hand, another distinct early stage human
NSCs were reported recently (Noisa et al., 2012). Different
from SSEA4(+)/Tra-1–81(+) human ESCs and SSEA4(−)/
Tra-1–81(−) mature human NSCs, the early staged human
NSCs derived by Noisa et al. still express SSEA4 like human
ESCs, while their partial commitment was shown by the
silencing of Tra-1–81 gene (Noisa et al., 2012). Contrary to
our mouse ESC-derived primitive NSCs, switching back to
human ESC medium cannot reverse the partial commitment
of these early human NSCs, instead, it led to the loss of both
ESC and NSC identity after re-plating (Noisa et al., 2012). It
is possible that these early stage human NSCs were committed
to a later neural cell fate comparedwith our primitive NSCs, as
they showed partial down-regulation of pluripotency genes,
significant up-regulation of mature neural genes and increased
methylation of Oct4 promoter (Noisa et al., 2012).
Clearly, discrepancy exists between different studies on
early stage NSCs derived from mouse and human ESCs. Since
human and mouse ESCs are inherently different, it will be of
interest to address whether similar primitive NSCs could be
derived from human and from which stage a conserved
common scheme is used in the neural induction by both
human and mouse. Given the fact that CNS-NSCs can
self-renew in the form of suspension spheres, the neural
induction in suspension culture likely provides more suitable
settings for maintaining self-renewal of the primitive NSCs
derived from human ESCs.
Collectively, our study uncovered new features of p-NSCs,
and provided insightful understanding of early neural induc-
tion as well as valuable source of data for further investigation
into this early staged neural cell type. It will facilitate the
illustration of the detailed regulatory network of neural
induction and contribute to the development of regenerative
medicine using ESC-derived neural cells.Conflict of interest
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